TipRanks
Ligand Pharma (DE:LGDN)
FRANKFURT:LGDN
Germany Market
LGDN
Ligand Pharma
RESEARCH TOOLSreports

Ligand Pharma (LGDN) Ratios

1 Followers

Ligand Pharma Ratios

DE:LGDN's free cash flow for Q2 2026 was $0.95. For the 2026 fiscal year, DE:LGDN's free cash flow was decreased by $ and operating cash flow was $1.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 31.18 22.23 8.93 14.15 2.67
Quick Ratio
 30.96 21.98 8.55 12.72 2.53
Cash Ratio
 21.54 4.67 1.95 1.37 0.46
Solvency Ratio
 0.19 0.29 0.28 1.03 0.06
Operating Cash Flow Ratio
 2.82 1.32 2.61 2.95 1.40
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 1.80
Net Current Asset Value
$ 238.76M$ 288.85M$ 220.22M$ 151.13M$ 98.42M
Leverage Ratios
Debt-to-Assets Ratio
 0.52 0.29 <0.01 <0.01 0.12
Debt-to-Equity Ratio
 1.17 0.44 <0.01 <0.01 0.15
Debt-to-Capital Ratio
 0.54 0.31 <0.01 <0.01 0.13
Long-Term Debt-to-Capital Ratio
 0.54 0.30 0.00 0.00 0.00
Financial Leverage Ratio
 2.26 1.53 1.13 1.12 1.28
Debt Service Coverage Ratio
 37.64 33.56 11.28 138.71 0.51
Interest Coverage Ratio
 16.31 10.01 -7.44 18.20 1.69
Debt to Market Cap
 0.18 0.12 0.00 0.00 0.07
Interest Debt Per Share
 56.70 23.59 0.55 0.39 5.31
Net Debt to EBITDA
 0.46 1.43 -1.60 -0.17 0.53
Profitability Margins
Gross Profit Margin
98.58%97.54%93.37%73.31%73.08%
EBIT Margin
82.50%59.29%3.32%48.98%19.27%
EBITDA Margin
94.22%71.89%24.41%76.79%41.38%
Operating Profit Margin
34.74%17.61%-13.53%9.09%1.55%
Pretax Profit Margin
81.90%59.29%1.51%48.48%18.35%
Net Profit Margin
67.88%46.42%-2.41%39.72%-17.00%
Continuous Operations Profit Margin
67.88%46.42%-2.41%40.98%-2.66%
Net Income Per EBT
82.88%78.29%-160.13%81.93%-92.64%
EBT Per EBIT
235.77%336.79%-11.14%533.08%1185.74%
Return on Assets (ROA)
9.02%7.97%-0.43%6.63%-4.37%
Return on Equity (ROE)
20.06%12.23%-0.49%7.44%-5.58%
Return on Capital Employed (ROCE)
4.72%3.10%-2.50%1.55%0.46%
Return on Invested Capital (ROIC)
3.91%2.42%4.00%1.31%-0.06%
Return on Tangible Assets
10.52%12.00%-0.71%13.57%-10.96%
Earnings Yield
3.15%3.40%-0.21%4.22%-2.96%
Efficiency Ratios
Receivables Turnover
 4.16 4.39 3.94 3.34 5.60
Payables Turnover
 0.44 2.03 2.12 14.44 9.95
Inventory Turnover
 0.40 0.72 0.78 1.46 3.97
Fixed Asset Turnover
 45.12 24.84 6.74 5.24 7.14
Asset Turnover
 0.13 0.17 0.18 0.17 0.26
Working Capital Turnover Ratio
 0.26 0.49 0.65 0.68 0.67
Cash Conversion Cycle
 163.84 409.36 385.42 333.61 120.35
Days of Sales Outstanding
 87.84 83.12 92.70 109.27 65.17
Days of Inventory Outstanding
 909.11 505.65 465.20 249.61 91.85
Days of Payables Outstanding
 833.11 179.41 172.48 25.27 36.67
Operating Cycle
 996.95 588.77 557.90 358.88 157.02
Cash Flow Ratios
Operating Cash Flow Per Share
 6.56 2.55 5.31 2.87 8.17
Free Cash Flow Per Share
 6.55 2.53 4.23 -0.25 7.11
CapEx Per Share
 0.01 0.02 1.07 3.11 1.06
Free Cash Flow to Operating Cash Flow
 1.00 0.99 0.80 -0.09 0.87
Dividend Paid and CapEx Coverage Ratio
 473.54 109.20 4.94 0.92 7.69
Capital Expenditure Coverage Ratio
 473.54 109.20 4.94 0.92 7.69
Operating Cash Flow Coverage Ratio
 0.12 0.11 13.66 8.04 1.57
Operating Cash Flow to Sales Ratio
 0.45 0.18 0.58 0.38 0.70
Free Cash Flow Yield
2.10%1.34%3.95%-0.35%10.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 31.21 29.36 -487.05 23.69 -33.78
Price-to-Sales (P/S) Ratio
 21.55 13.64 11.73 9.41 5.74
Price-to-Book (P/B) Ratio
 6.48 3.59 2.36 1.76 1.89
Price-to-Free Cash Flow (P/FCF) Ratio
 47.66 74.76 25.32 -289.19 9.40
Price-to-Operating Cash Flow Ratio
 47.61 74.07 20.19 24.92 8.17
Price-to-Earnings Growth (PEG) Ratio
 0.03 >-0.01 4.54 -0.09 0.21
Price-to-Fair Value
 6.48 3.59 2.36 1.76 1.89
Enterprise Value Multiple
 23.32 20.41 46.44 12.09 14.40
Enterprise Value
 6.38B 3.93B 1.89B 1.22B 1.17B
EV to EBITDA
 23.32 20.41 46.44 12.09 14.40
EV to Sales
 21.98 14.67 11.34 9.28 5.96
EV to Free Cash Flow
 48.60 80.41 24.48 -285.26 9.75
EV to Operating Cash Flow
 48.50 79.68 19.52 24.58 8.48
Tangible Book Value Per Share
 32.73 25.51 25.07 17.22 8.25
Shareholders’ Equity Per Share
 48.22 52.60 45.40 40.52 35.42
Tax and Other Ratios
Effective Tax Rate
 0.17 0.22 2.60 0.15 1.14
Revenue Per Share
 14.48 13.86 9.14 7.59 11.63
Net Income Per Share
 9.83 6.44 -0.22 3.02 -1.98
Tax Burden
 0.83 0.78 -1.60 0.82 -0.93
Interest Burden
 0.99 1.00 0.45 0.99 0.95
Research & Development to Revenue
 0.14 0.30 0.13 0.19 0.18
SG&A to Revenue
 0.36 0.34 0.47 0.40 0.36
Stock-Based Compensation to Revenue
 0.18 0.00 0.25 0.20 0.31
Income Quality
 0.67 0.40 -24.07 0.95 -4.13
Currency in USD